WILMINGTON, DE — Incyte (Nasdaq: INCY) announced that it will participate in two high-profile investor conferences in November, where company leaders will discuss ongoing innovation and pipeline progress across its oncology and immunology portfolios.
The biopharmaceutical company will present at the Guggenheim Annual Healthcare Innovation Conference on Monday, November 10, 2025, at 10:00 a.m. EST, followed by the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025, at 11:00 a.m. GMT. Both presentations will be webcast live at Investor.Incyte.com and remain available for replay for 30 days.
Headquartered in Wilmington, Delaware, Incyte is a global biopharmaceutical leader focused on discovering, developing, and commercializing innovative medicines for patients with unmet medical needs. The company’s growing portfolio includes first-in-class treatments in Oncology and Inflammation & Autoimmunity, supported by a robust research pipeline and global operations spanning North America, Europe, and Asia.
Incyte’s participation in these major industry events reinforces its commitment to transparency with investors and its continued focus on advancing science-driven solutions for patients worldwide.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.